RelA-Induced Interferon Response Negatively Regulates Proliferation

by Kochupurakkal, Bose S., Wang, Zhigang C., Hua, Tony, Culhane, Aedin C., Rodig, Scott J., Rajkovic-Molek, Koraljka, Lazaro, Jean-Bernard, Richardson, Andrea L., Biswas, Debajit K., Iglehart, J. Dirk
Published 2015

Pan-cancer analysis of genomic scar signatures associated with homologous recombination deficiency suggests novel indications for existing cancer drugs

by Marquard, Andrea M, Eklund, Aron C, Joshi, Tejal, Krzystanek, Marcin, Favero, Francesco, Wang, Zhigang C, Richardson, Andrea L, Silver, Daniel P, Szallasi, Zoltan, Birkbak, Nicolai J
Published 2015

Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations

by Birkbak, Nicolai Juul, Kochupurakkal, Bose, Izarzugaza, Jose M. G., Eklund, Aron C., Li, Yang, Liu, Joyce, Szallasi, Zoltan, Matulonis, Ursula A., Richardson, Andrea L., Iglehart, J. Dirk, Wang, Zhigang C.
Published 2013

PRKACA Mediates Resistance to HER2-Targeted Therapy in Breast Cancer Cells and Restores Anti-Apoptotic Signaling

by Moody, Susan E., Schinzel, Anna C., Singh, Shambhavi, Izzo, Francesca, Strickland, Matthew R., Luo, Leo, Thomas, Sapana R., Boehm, Jesse S., Kim, So Young, Wang, Zhigang C., Hahn, William C.
Published 2014

Combination inhibition of PI3K and mTORC1 yields durable remissions in orthotopic patient-derived xenografts of HER2-positive breast cancer brain metastases

by Ni, Jing, Ramkissoon, Shakti H., Xie, Shaozhen, Goel, Shom, Stover, Daniel G., Guo, Hanbing, Luu, Victor, Marco, Eugenio, Ramkissoon, Lori A., Kang, Yun Jee, Hayashi, Marika, Nguyen, Quang-De, Ligon, Azra H., Du, Rose, Claus, Elizabeth B., Alexander, Brian M., Yuan, Guo-Cheng, Wang, Zhigang C., Iglehart, J. Dirk, Krop, Ian E., Roberts, Thomas M., Winer, Eric P., Lin, Nancy U., Ligon, Keith L., Zhao, Jean J.
Published 2016